Efficacy of chemical disinfectants against SARS-CoV-2 on high-touch surface materials
This study aimed to provide operationally relevant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) surface disinfection efficacy information. Three EPA-registered disinfectants (Vital Oxide, Peroxide, and Clorox Total 360) and one antimicrobial formulation (CDC bleach) were evaluated ag...
Saved in:
Published in: | Journal of applied microbiology |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
England
15-12-2022
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | This study aimed to provide operationally relevant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) surface disinfection efficacy information.
Three EPA-registered disinfectants (Vital Oxide, Peroxide, and Clorox Total 360) and one antimicrobial formulation (CDC bleach) were evaluated against SARS-CoV-2 on material coupons and were tested using Spray (no touch with contact time) and Spray & Wipe (wipe immediately post-application) methods immediately and 2 h post-contamination. Efficacy was evaluated for infectious virus, with a subset tested for viral RNA (vRNA) recovery. Efficacy varied by method, disinfectant, and material. CDC bleach solution showed low efficacy against SARS-CoV-2 (log reduction < 1.7), unless applied via Spray & Wipe. Additionally, mechanical wiping increased the efficacy of treatments against SARS-CoV-2. The recovery of vRNA post-disinfection suggested that vRNA may overestimate infectious virus remaining.
Efficacy depends on surface material, chemical, and disinfection procedure, and suggests that mechanical wiping alone has some efficacy at removing SARS-CoV-2 from surfaces. We observed that disinfectant treatment biased the recovery of vRNA over infectious virus.
These data are useful for developing effective, real-world disinfection procedures, and inform public health experts on the utility of PCR-based surveillance approaches. |
---|---|
Bibliography: | All authors listed contributed to this work and are entitled to authorship. S.W.N. and R.L.H. contributed equally to this work. B.T., R.L., and J.M. conducted assays, cell culture, and product efficacy testing at Battelle Eastern Science & Technology Center. M.W.H. and M.W.C. provided statistical analysis. R.R.J., M.W.C., S.D.L., M.J.S., S.P.R., and M.W.H. designed the study. R.R.J., M.W.C., S.D.L., M.J.S., S.P.R., and B.T. assisted with manuscript preparation. M.W.H., R.L.H., and S.W.N. coordinated and implemented the study, developed protocols, analyzed the data. M.W.H. drafted the manuscript. These authors contributed equally and are listed in alphabetical order. Author contributions |
ISSN: | 1364-5072 1365-2672 |
DOI: | 10.1093/jambio/lxac020 |